Clinicians can bill Category 1 CPT Code 75580 for adjunctive use of the artificial intelligence (AI)-powered Cleerly Ischemia software for fractional flow reserve estimates based on coronary computed tomography angiography (CCTA) scans.
A new Category 1 CPT code may enhance reimbursement for the use of adjunctive artificial intelligence (AI)-enabled software to ascertain fractional flow reserve (FFR) estimates in cases of suspected coronary artery disease (CAD).
The Cleerly Ischemia software (Cleerly), which can now be billed with the Category 1 CPT code 75580, allows non-invasive lesion mapping for findings of CAD, according to Cleerly, the develop of the Cleerly Ischemia software.
Adjunctive use of the Cleerly Ischemia (Cleerly) software for CCTA-based fractional flow reserve estimates can now be billed with the new Category I CPT code 75580. (Image courtesy of Cleerly.)
“The Cleerly Ischemia software provides noninvasive estimates of FFR values that help healthcare professionals make critical decisions in the management of patients with suspected coronary artery disease,” noted James P. Earls, M.D, the chief medical officer of Cleerly. “Cleerly Ischemia was purposely designed to output estimates of FFR values that are guideline-recommended by professional societies, and to allow comprehensive mapping of both anatomic and physiologic data for each and every coronary lesion across the entire vascular tree.”
Cleerly noted the new Category 1 CPT code is an addition to previously established Category III CPT codes for billing of the company’s advanced coronary atherosclerosis analysis.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.